comparemela.com

Page 2 - James Triccas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

World News | CEPI Partners with Bharat Biotech, University of Sydney, ExcellGene to Develop variant-proof COVID-19 Vaccine

The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced the latest award under its USD 200 m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses. Bharat Biotech Consortium Gets $19 Million Funding For Development of Variant Proof COVID-19 Vaccine.

CEPI Partners with Bharat Biotech Consortium to Develop Variant-Proof COVID-19 Vaccine

OSLO, Norway/ HYDERABAD, India/ SYDNEY, Australia/ MONTHEY, Switzerland: The Coalition for Epidemic Preparedness Innovations (CEPI) today announces the latest award under its $200m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other betacoronaviruses.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.